相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
Dara O. Kavanagh et al.
BMC CANCER (2009)
Vascular Endothelial Growth Factor Polymorphisms and Esophageal Cancer Prognosis
Penelope A. Bradbury et al.
CLINICAL CANCER RESEARCH (2009)
ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery
Glauco Baiocchi et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100
Bryan P. Schneider et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
HER-2/neu overexpression is an independent prognostic factor in colorectal cancer
Dong Il Park et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2007)
Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200
Bruce J. Giantonio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
HER 2/neu protein expression in colorectal cancer
B. Schuell et al.
BMC CANCER (2006)
ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells
KS Klos et al.
CANCER RESEARCH (2006)
Vascular endothelial growth factor messenger RNA expression level is preserved in liver metastases compered with corresponding primary colorectal cancer
H Kuramochi et al.
CLINICAL CANCER RESEARCH (2006)
Addition of bevacizurnab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: Results of a randomized phase II trial
FF Kabbinavar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers
L Yen et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma
WT Yang et al.
CANCER (2002)
c-erbB-2 is not a major factor in the development of colorectal cancer
JA McKay et al.
BRITISH JOURNAL OF CANCER (2002)
Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer
H Han et al.
HUMAN PATHOLOGY (2002)
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.
DJ Slamon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis
L Yen et al.
ONCOGENE (2000)
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
JC Lee et al.
EUROPEAN JOURNAL OF CANCER (2000)
分享论文
